Updates matching "National"

The National Institutes of Standards and Technology proposed new guidance late last week that seeks to expand conditions under which federal government agencies can apply march-in rights, a provision of the 1980 Bayh-Doyle Act, to include consideration for pricing of pharmaceutical drugs.

Tomorrow, the U.S. Senate Health Education Labor and Pension Committee (HELP) is expected to mark up the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act, S.1840. This bill would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2028.

Nearly two years after the U.S. Food and Drug Administration (FDA) released its proposed rules to eliminate menthol in cigarettes and all flavors in cigars, the administration/White House announced today it will further delay release of final rules. Dr. Karen E. Knudsen, CEO of the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN), released the following statement:

Today, the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to key Congressional leaders urging them to advance legislation that comprehensively addresses the nation’s ongoing drug shortage crisis ahead of a Senate Finance Committee hearing Tuesday.

The House Labor, Health and Human Services funding bill is scheduled to be considered by the House Rules Committee today.

The Senate confirmed Dr. Monica M. Bertagnolli, MD, as the new director of the National Institutes of Health (NIH) today.

New data from the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention’s (CDC) National Youth Tobacco Survey (NYTS) found that more than 6.21 million youth reported ever using tobacco products and 2.8 million report current use (past 30 days) of any tobacco product in 2023.

A new national poll reveals that patients are counting on lawmakers to solve the medical debt crisis. U.S. adults say it is past time for federal and state policymakers to act.

The nation’s drug shortage crisis continues to affect cancer patients and survivors with 1 in every 10 (10%) reporting impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (45%). The data is part of a new survey by the American Cancer Society Cancer Action Network (ACS CAN).